July 2021 | Suzhou

From July 10 - 12, the 3rd Biopharmaceutical Frontier Technology Conference by Tongxieyi under the theme of "Gathering Frontier Technology, Breaking through Innovations from source" was successfully held at Suzhou International Expo Center by the side of Jinji Lake, which was a breakthrough upgrade from the previous two Global Biopharmaceutical Frontier Technology Conferences and led the direction of industrial innovation. Elixir Clinical Research debuted at the conference to exchange and learn from industry colleagues.

Conference review

The Biopharmaceutical Frontier Technology Conference reached unprecedented scale, with 21 thematic forums, 50+ top scientists, 150+ exhibitors, 500+ new drug leaders and 5,000+ new drug practitioners gathering together to bring the most cutting-edge academic vision to the industry. As a technology-enabled full service CRO, Elixir Clinical Research joined the exhibition for the first time, and received wide attentions, a lot of inquiries from new and existing clients, and fruitful communication, which made us look forward to the future development of biopharmaceutical innovation in China.

Quest of medicines

Innovate from sources

With the influx of capital, China's innovative drug industry is booming, and the demand for clinical study by pharmaceutical and medical device companies is increasing on a daily basis. There are opportunities and challenges lying ahead for the industry's future development trend. As a technology-enabled full service CRO, Elixir Clinical Research empowers the whole process of clinical study project management and operation with digital technology compared with traditional CROs, and has a team of experienced experts capable of providing clients with high-speed, efficient and transparent high-quality services in important processes of clinical study such as clinical study protocol design, medical strategy, regulatory registration, site management, data management and biostatistics.

Despite the short three-day gathering, the enthusiasm for biopharmaceutical innovation and development will never stop. Elixir Clinical Research will continue to adhere to its mission of "Making good drugs accessible", always insist on scientific and technological innovation to empower clinical study, provide high-quality and effective clinical study solutions for pharmaceutical and medical device companies, and facilitate the "last mile" of pharmaceutical R&D!